Article Search
검색
검색 팝업 닫기

Metrics

Help

  • 1. Aims and Scope

    Gut and Liver is an international journal of gastroenterology, focusing on the gastrointestinal tract, liver, biliary tree, pancreas, motility, and neurogastroenterology. Gut atnd Liver delivers up-to-date, authoritative papers on both clinical and research-based topics in gastroenterology. The Journal publishes original articles, case reports, brief communications, letters to the editor and invited review articles in the field of gastroenterology. The Journal is operated by internationally renowned editorial boards and designed to provide a global opportunity to promote academic developments in the field of gastroenterology and hepatology. +MORE

  • 2. Editorial Board

    Editor-in-Chief + MORE

    Editor-in-Chief
    Yong Chan Lee Professor of Medicine
    Director, Gastrointestinal Research Laboratory
    Veterans Affairs Medical Center, Univ. California San Francisco
    San Francisco, USA

    Deputy Editor

    Deputy Editor
    Jong Pil Im Seoul National University College of Medicine, Seoul, Korea
    Robert S. Bresalier University of Texas M. D. Anderson Cancer Center, Houston, USA
    Steven H. Itzkowitz Mount Sinai Medical Center, NY, USA
  • 3. Editorial Office
  • 4. Articles
  • 5. Instructions for Authors
  • 6. File Download (PDF version)
  • 7. Ethical Standards
  • 8. Peer Review

    All papers submitted to Gut and Liver are reviewed by the editorial team before being sent out for an external peer review to rule out papers that have low priority, insufficient originality, scientific flaws, or the absence of a message of importance to the readers of the Journal. A decision about these papers will usually be made within two or three weeks.
    The remaining articles are usually sent to two reviewers. It would be very helpful if you could suggest a selection of reviewers and include their contact details. We may not always use the reviewers you recommend, but suggesting reviewers will make our reviewer database much richer; in the end, everyone will benefit. We reserve the right to return manuscripts in which no reviewers are suggested.

    The final responsibility for the decision to accept or reject lies with the editors. In many cases, papers may be rejected despite favorable reviews because of editorial policy or a lack of space. The editor retains the right to determine publication priorities, the style of the paper, and to request, if necessary, that the material submitted be shortened for publication.

Search

Search

Year

to

Article Type

ahead

Split Viewer

Online first

Clinical Features and Long-term Prognosis of Crohn’s Disease in Korea: Results from the Prospective CONNECT Study

Seung Wook Hong1,2 , Byong Duk Ye1,2,3 , Jae Hee Cheon4 , Ji Hyun Lee5 , Ja Seol Koo6 , Byung Ik Jang7 , Kang-Moon Lee8 , You Sun Kim9 , Tae Oh Kim10 , Jong Pil Im11 , Geun Am Song12 , Sung-Ae Jung13 , Hyun Soo Kim14 , Dong Il Park15 , Hyun-Soo Kim16 , Kyu Chan Huh17 , Young-Ho Kim18 , Jae Myung Cha19 , Geom Seog Seo20 , Chang Hwan Choi21 , Hyun Joo Song22 , Gwang Ho Baik23 , Ji Won Kim24 , Sung Jae Shin25 , Young Sook Park26 , Chang Kyun Lee27 , Jun Lee28 , Sung Hee Jung29 , Yunho Jung30 , Sung Chul Park31 , Young-Eun Joo14 , Yoon Tae Jeen32 , Dong Soo Han33 , Suk-Kyun Yang1,2,3 , Hyo Jong Kim27 , Won Ho Kim4 , and Joo Sung Kim11

1Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 2Digestive Diseases Research Center, University of Ulsan College of Medicine, 3Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, 4Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, 5Digestive Endoscopic Center, Seoul Song Do Colorectal Hospital, Seoul, 6Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Ansan, 7Division of Gastroenterology and Hepatology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, 8Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Suwon, 9Department of Internal Medicine, Inje University Seoul Paik Hospital, Inje University College of Medicine, Seoul, 10Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, 11Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, 12Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, 13Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, 14Department of Internal Medicine, Chonnam National University Medical School, Gwangju, 15Division of Gastroenterology, Department of Internal Medicine and Gastrointestinal Cancer Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, 16Division of Gastroenterology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, 17Division of Gastroenterology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, 18Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 19Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, 20Department of Internal Medicine, Digestive Disease Research Institute, Wonkwang University College of Medicine, Iksan, 21Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, 22Department of Internal Medicine, Jeju National University College of Medicine, Jeju, 23Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, 24Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul National University of College of Medicine, Seoul, 25Department of Gastroenterology, Ajou University School of Medicine, Suwon, 26Division of Gastroenterology, Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, 27Department of Internal Medicine, College of Medicine, Kyung Hee University, Seoul, 28Department of Internal Medicine, Chosun University College of Medicine, Gwangju, 29Department of Internal Medicine, Daejeon Eulji Medical Center, Eulji University College of Medicine, Daejeon, 30Department of Internal Medicine, Soonchunhyang University College of Medicine, Cheonan, 31Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, 32Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, and 33Division of Gastroenterology, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea

Correspondence to:Byong Duk Ye
ORCID https://orcid.org/0000-0001-6647-6325
E-mail bdye@amc.seoul.kr
Joo Sung Kim
ORCID https://orcid.org/0000-0001-6835-4735
E-mail jooskim@snu.ac.kr

Received: July 1, 2021; Revised: October 27, 2021; Accepted: December 3, 2021

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Gut Liver

Published online March 24, 2022

Copyright © Gut and Liver.

Abstract

Background/Aims: The prospective Crohn’s Disease Clinical Network and Cohort study is a nationwide multicenter cohort study of patients with Crohn’s disease (CD) in Korea, aiming to prospectively investigate the clinical features and long-term prognosis associated with CD.
Methods: Patients diagnosed with CD between January 2009 and September 2019 were prospectively enrolled. They were divided into two cohorts according to the year of diagnosis: cohort 1 (diagnosed between 2009 and 2011) versus cohort 2 (between 2012 and 2019).
Results: A total of 1,175 patients were included, and the median follow-up duration was 68 months (interquartile range, 39.0 to 91.0 months). The treatment-free durations for thiopurines (p<0.001) and anti-tumor necrosis factor agents (p=0.018) of cohort 2 were shorter than those of cohort 1. Among 887 patients with B1 behavior at diagnosis, 149 patients (16.8%) progressed to either B2 or B3 behavior during follow-up. Early use of thiopurine was associated with a reduced risk of behavioral progression (adjusted hazard ratio [aHR], 0.69; 95% confidence interval [CI], 0.50 to 0.90), and family history of inflammatory bowel disease was associated with an increased risk of behavioral progression (aHR, 2.29; 95% CI, 1.16 to 4.50). One hundred forty-one patients (12.0%) underwent intestinal resection, and the intestinal resection-free survival time was significantly longer in cohort 2 than in cohort 1 (p=0.003). The early use of thiopurines (aHR, 0.35; 95% CI, 0.23 to 0.51) was independently associated with a reduced risk of intestinal resection.
Conclusions: The prognosis of CD in Korea appears to have improved over time, as evidenced by the decreasing intestinal resection rate. Early use of thiopurines was associated with an improved prognosis represented by a reduced risk of intestinal resection.

Keywords: Cohort studies, Crohn disease, Prognosis, Multicenter study, Korea


Article

ahead

Gut and Liver

Published online March 24, 2022

Copyright © Gut and Liver.

Clinical Features and Long-term Prognosis of Crohn’s Disease in Korea: Results from the Prospective CONNECT Study

Seung Wook Hong1,2 , Byong Duk Ye1,2,3 , Jae Hee Cheon4 , Ji Hyun Lee5 , Ja Seol Koo6 , Byung Ik Jang7 , Kang-Moon Lee8 , You Sun Kim9 , Tae Oh Kim10 , Jong Pil Im11 , Geun Am Song12 , Sung-Ae Jung13 , Hyun Soo Kim14 , Dong Il Park15 , Hyun-Soo Kim16 , Kyu Chan Huh17 , Young-Ho Kim18 , Jae Myung Cha19 , Geom Seog Seo20 , Chang Hwan Choi21 , Hyun Joo Song22 , Gwang Ho Baik23 , Ji Won Kim24 , Sung Jae Shin25 , Young Sook Park26 , Chang Kyun Lee27 , Jun Lee28 , Sung Hee Jung29 , Yunho Jung30 , Sung Chul Park31 , Young-Eun Joo14 , Yoon Tae Jeen32 , Dong Soo Han33 , Suk-Kyun Yang1,2,3 , Hyo Jong Kim27 , Won Ho Kim4 , and Joo Sung Kim11

1Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 2Digestive Diseases Research Center, University of Ulsan College of Medicine, 3Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, 4Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, 5Digestive Endoscopic Center, Seoul Song Do Colorectal Hospital, Seoul, 6Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Ansan, 7Division of Gastroenterology and Hepatology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, 8Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Suwon, 9Department of Internal Medicine, Inje University Seoul Paik Hospital, Inje University College of Medicine, Seoul, 10Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, 11Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, 12Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, 13Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, 14Department of Internal Medicine, Chonnam National University Medical School, Gwangju, 15Division of Gastroenterology, Department of Internal Medicine and Gastrointestinal Cancer Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, 16Division of Gastroenterology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, 17Division of Gastroenterology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, 18Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 19Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, 20Department of Internal Medicine, Digestive Disease Research Institute, Wonkwang University College of Medicine, Iksan, 21Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, 22Department of Internal Medicine, Jeju National University College of Medicine, Jeju, 23Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, 24Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul National University of College of Medicine, Seoul, 25Department of Gastroenterology, Ajou University School of Medicine, Suwon, 26Division of Gastroenterology, Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, 27Department of Internal Medicine, College of Medicine, Kyung Hee University, Seoul, 28Department of Internal Medicine, Chosun University College of Medicine, Gwangju, 29Department of Internal Medicine, Daejeon Eulji Medical Center, Eulji University College of Medicine, Daejeon, 30Department of Internal Medicine, Soonchunhyang University College of Medicine, Cheonan, 31Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, 32Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, and 33Division of Gastroenterology, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea

Correspondence to:Byong Duk Ye
ORCID https://orcid.org/0000-0001-6647-6325
E-mail bdye@amc.seoul.kr
Joo Sung Kim
ORCID https://orcid.org/0000-0001-6835-4735
E-mail jooskim@snu.ac.kr

Received: July 1, 2021; Revised: October 27, 2021; Accepted: December 3, 2021

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background/Aims: The prospective Crohn’s Disease Clinical Network and Cohort study is a nationwide multicenter cohort study of patients with Crohn’s disease (CD) in Korea, aiming to prospectively investigate the clinical features and long-term prognosis associated with CD.
Methods: Patients diagnosed with CD between January 2009 and September 2019 were prospectively enrolled. They were divided into two cohorts according to the year of diagnosis: cohort 1 (diagnosed between 2009 and 2011) versus cohort 2 (between 2012 and 2019).
Results: A total of 1,175 patients were included, and the median follow-up duration was 68 months (interquartile range, 39.0 to 91.0 months). The treatment-free durations for thiopurines (p<0.001) and anti-tumor necrosis factor agents (p=0.018) of cohort 2 were shorter than those of cohort 1. Among 887 patients with B1 behavior at diagnosis, 149 patients (16.8%) progressed to either B2 or B3 behavior during follow-up. Early use of thiopurine was associated with a reduced risk of behavioral progression (adjusted hazard ratio [aHR], 0.69; 95% confidence interval [CI], 0.50 to 0.90), and family history of inflammatory bowel disease was associated with an increased risk of behavioral progression (aHR, 2.29; 95% CI, 1.16 to 4.50). One hundred forty-one patients (12.0%) underwent intestinal resection, and the intestinal resection-free survival time was significantly longer in cohort 2 than in cohort 1 (p=0.003). The early use of thiopurines (aHR, 0.35; 95% CI, 0.23 to 0.51) was independently associated with a reduced risk of intestinal resection.
Conclusions: The prognosis of CD in Korea appears to have improved over time, as evidenced by the decreasing intestinal resection rate. Early use of thiopurines was associated with an improved prognosis represented by a reduced risk of intestinal resection.

Keywords: Cohort studies, Crohn disease, Prognosis, Multicenter study, Korea

Gut and Liver

Vol.16 No.3
May, 2022

pISSN 1976-2283
eISSN 2005-1212

qrcode
qrcode

Share this article on :

  • line

Popular Keywords

Gut and LiverQR code Download
qr-code

Editorial Office